ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Orion Corporation, Orion Pharma clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 101 studies whose lead sponsor is Orion Corporation, Orion Pharma. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 5, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Orion Corporation, Orion Pharma with Hansoh Pharmaceutical Group and Vanda Pharmaceuticals →

Pipeline: 3 programs

Each counted once: 3 with a study Orion Corporation, Orion Pharma leads registered in the last two years.

  • Phase 2

The 3 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Orion Corporation, Orion Pharma’s own registered studies; Orion Corporation, Orion Pharma’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

One of Orion Corporation, Orion Pharma’s programs has a dated deal behind it: 1 licensed out. Each from the companies’ own releases and filings, linked; the registry does not record them.

Licensed out 1

What it is testing

The drugs Orion Corporation, Orion Pharma’s studies test, most studies first; none is open now — 23 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Show 13 more

All 101 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now33%
  • Under way, not recruiting11%
  • Completed8988%
  • Stopped early88%

Phase

  • Phase 158
  • Phase 222
  • Phase 49
  • Phase 38
  • Early Phase 11

Where

  • Finland66
  • Germany19
  • United Kingdom19
  • France14
  • Sweden10
  • Netherlands7

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 1111
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 226

By the year each study started; 8 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Orion Corporation, Orion Pharma.

  • Orion Corporation, Orion Pharma
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    101 studies

Focus areas

Conditions Orion Corporation, Orion Pharma leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 101. Browse all 101 →